19.01.2015 Views

2294 part 1 final report.pdf - Agra CEAS Consulting

2294 part 1 final report.pdf - Agra CEAS Consulting

2294 part 1 final report.pdf - Agra CEAS Consulting

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Prevention and control of animal diseases worldwide<br />

Part I: Economic analysis: prevention versus outbreak costs<br />

excluding consequential on-farm losses and US$ 23.5 billion if these losses are included. Moving towards<br />

scenarios B and C these costs increase further to US$ 12.3 billion and US$ 26.9 billion respectively (in the<br />

case of scenario B) and to US$ 19.4 billion and US$ 42.7 billion respectively (in the case of scenario C).<br />

Before even considering the indirect impacts the benefits of improved prevention therefore by far<br />

outweigh the potential outbreak costs and losses.<br />

Figure B: Prevention versus outbreak costs: comparison under various scenarios, HPAI<br />

Total impact including ripple (domestic and export market),<br />

most likely scenario / A (total)<br />

Total impact including ripple (domestic and export market),<br />

most likely scenario / A (annual)<br />

Total direct impact (incl. consequential losses), most likely<br />

scenario / B (total)<br />

Total direct impact (incl. consequential losses), most likely<br />

scenario / B (annual)<br />

Total direct impact (incl. consequential losses), most likely<br />

scenario / A (total)<br />

Total direct impact (incl. consequential losses), most likely<br />

scenario / A (annual)<br />

Direct production costs/losses, most likely scenario / A<br />

(total)<br />

Direct production costs/losses, most likely scenario / A<br />

(annual)<br />

Prevention and control of HPAI: global needs (WB)<br />

Prevention system for HPAI: global needs (WB)<br />

0.0 5.0 10.0 15.0 20.0 25.0 30.0 35.0 40.0 45.0<br />

billion US$<br />

Notes:<br />

HPAI global needs figures are totals over a 3 year period;<br />

Incremental operational costs (a significant <strong>part</strong> of the total costs of strengthening VS) are excluded from these<br />

calculations, due to lack of data;<br />

Outbreak costs are quoted in annual and total amounts (total here refers to the duration of the impact, which is<br />

assumed to last for 2 years in the most likely scenario).<br />

Source: “OIE Del1 global costs analysis.xls”, <strong>Agra</strong> <strong>CEAS</strong> <strong>Consulting</strong>.<br />

The <strong>report</strong> concludes by noting that it is difficult to predict the severity of the threats posed by<br />

Transboundary Animal Diseases (TADs). Moreover, different issues arise depending on the nature of the<br />

disease. A disease such as HPAI, with its high public health relevance, poses a different set of challenges<br />

than a disease such as FMD which has purely commercial and socio-economic implications. Both<br />

Civic <strong>Consulting</strong> • <strong>Agra</strong> <strong>CEAS</strong> <strong>Consulting</strong> 13

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!